These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 25156691)

  • 1. Cardiovascular magnetic resonance tagging imaging correlates with myocardial dysfunction and T2 mapping in idiopathic dilated cardiomyopathy.
    Kono AK; Croisille P; Nishii T; Nishiyama K; Kyotani K; Shigeru M; Takamine S; Fujiwara S; Sugimura K
    Int J Cardiovasc Imaging; 2014 Dec; 30 Suppl 2():145-52. PubMed ID: 25156691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of myocardial fibrosis and ventricular dyssynchrony on response to therapy in new-presentation idiopathic dilated cardiomyopathy: insights from cardiovascular magnetic resonance and echocardiography.
    Leong DP; Chakrabarty A; Shipp N; Molaee P; Madsen PL; Joerg L; Sullivan T; Worthley SG; De Pasquale CG; Sanders P; Selvanayagam JB
    Eur Heart J; 2012 Mar; 33(5):640-8. PubMed ID: 22048681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular magnetic resonance T2 mapping can detect myocardial edema in idiopathic dilated cardiomyopathy.
    Nishii T; Kono AK; Shigeru M; Takamine S; Fujiwara S; Kyotani K; Aoyama N; Sugimura K
    Int J Cardiovasc Imaging; 2014 Jun; 30 Suppl 1():65-72. PubMed ID: 24715436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extracellular volume fraction in dilated cardiomyopathy patients without obvious late gadolinium enhancement: comparison with healthy control subjects.
    Hong YJ; Park CH; Kim YJ; Hur J; Lee HJ; Hong SR; Suh YJ; Greiser A; Paek MY; Choi BW; Kim TH
    Int J Cardiovasc Imaging; 2015 Jun; 31 Suppl 1():115-22. PubMed ID: 25634119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantification of left ventricular dyssynchrony in patients with systolic dysfunction: a comparison of circumferential strain MR-tagging metrics.
    El Ghannudi S; Germain P; Jeung MY; Breton E; Croisille P; Durand E; Roy C; Gangi A
    J Magn Reson Imaging; 2014 Nov; 40(5):1238-46. PubMed ID: 24925128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myocardial tissue characterization using magnetic resonance noncontrast t1 mapping in hypertrophic and dilated cardiomyopathy.
    Dass S; Suttie JJ; Piechnik SK; Ferreira VM; Holloway CJ; Banerjee R; Mahmod M; Cochlin L; Karamitsos TD; Robson MD; Watkins H; Neubauer S
    Circ Cardiovasc Imaging; 2012 Nov; 5(6):726-33. PubMed ID: 23071146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fat deposition in dilated cardiomyopathy assessed by CMR.
    Lu M; Zhao S; Jiang S; Yin G; Wang C; Zhang Y; Liu Q; Cheng H; Ma N; Zhao T; Chen X; Huang J; Zou Y; Song L; He Z; An J; Renate J; Xue H; Shah S
    JACC Cardiovasc Imaging; 2013 Aug; 6(8):889-98. PubMed ID: 23850250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myocardial fibrosis as a key determinant of left ventricular remodeling in idiopathic dilated cardiomyopathy: a contrast-enhanced cardiovascular magnetic study.
    Masci PG; Schuurman R; Andrea B; Ripoli A; Coceani M; Chiappino S; Todiere G; Srebot V; Passino C; Aquaro GD; Emdin M; Lombardi M
    Circ Cardiovasc Imaging; 2013 Sep; 6(5):790-9. PubMed ID: 23934992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of myocardial deformation with cardiac magnetic resonance strain imaging improves risk stratification in patients with dilated cardiomyopathy.
    Buss SJ; Breuninger K; Lehrke S; Voss A; Galuschky C; Lossnitzer D; Andre F; Ehlermann P; Franke J; Taeger T; Frankenstein L; Steen H; Meder B; Giannitsis E; Katus HA; Korosoglou G
    Eur Heart J Cardiovasc Imaging; 2015 Mar; 16(3):307-15. PubMed ID: 25246506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [T1 mapping and late gadolinium enhancement for the diagnosis of dilated cardiomyopathy].
    Cui Q; Yu J; Ge X; Gao G; Liu Y; Shen W
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 Dec; 32(12):1506-1510. PubMed ID: 33541506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of myocardial partition coefficient of gadolinium (λ) in dilated cardiomyopathy and its impact on segmental and global systolic function.
    Jacquier A; Kallifatidis A; Guibert N; Giorgi R; Falque C; Thuny F; Croisille P; Clarysse P; Maurel B; Flavian A; Gaubert JY; Moulin G; Habib G
    J Magn Reson Imaging; 2014 Dec; 40(6):1336-41. PubMed ID: 24989685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Late gadolinium enhancement on cardiac magnetic resonance imaging is associated with coronary endothelial dysfunction in patients with dilated cardiomyopathy.
    Nakayama M; Yamamuro M; Takashio S; Uemura T; Nakayama N; Hirakawa K; Oda S; Utsunomiya D; Kaikita K; Hokimoto S; Yamashita Y; Morita Y; Kimura K; Tamura K; Tsujita K
    Heart Vessels; 2018 Apr; 33(4):393-402. PubMed ID: 29051976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative mechanical dyssynchrony in dilated cardiomyopathy measured by deformable registration algorithm.
    Xu Y; He S; Li W; Wan K; Wang J; Mui D; Yang F; Liu H; Cheng W; Zhou X; Wetzl J; Sun J; Chen Y
    Eur Radiol; 2020 Apr; 30(4):2010-2020. PubMed ID: 31953665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation between left ventricular diastolic function and ejection fraction in dilated cardiomyopathy using magnetic resonance imaging with late gadolinium enhancement.
    Nanjo S; Yoshikawa K; Harada M; Inoue Y; Namiki A; Nakano H; Yamazaki J
    Circ J; 2009 Oct; 73(10):1939-44. PubMed ID: 19729860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T1 mapping in dilated cardiomyopathy with cardiac magnetic resonance: quantification of diffuse myocardial fibrosis and comparison with endomyocardial biopsy.
    aus dem Siepen F; Buss SJ; Messroghli D; Andre F; Lossnitzer D; Seitz S; Keller M; Schnabel PA; Giannitsis E; Korosoglou G; Katus HA; Steen H
    Eur Heart J Cardiovasc Imaging; 2015 Feb; 16(2):210-6. PubMed ID: 25246502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term prognostic value of combined free triiodothyronine and late gadolinium enhancement in nonischemic dilated cardiomyopathy.
    Zhang K; Wang W; Zhao S; Katz SD; Iervasi G; Gerdes AM; Tang YD
    Clin Cardiol; 2018 Jan; 41(1):96-103. PubMed ID: 29360143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical significance of discrepant mid-wall late gadolinium enhancement in patients with nonischemic dilated cardiomyopathy.
    Ehara S; Matsumoto K; Kitada R; Nishimura S; Shimada K; Yoshiyama M
    Heart Vessels; 2018 Dec; 33(12):1482-1489. PubMed ID: 29804280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Right ventricular dysfunction, late gadolinium enhancement, and female gender predict poor outcome in patients with dilated cardiomyopathy.
    Doesch C; Dierks DM; Haghi D; Schimpf R; Kuschyk J; Suselbeck T; Schoenberg SO; Borggrefe M; Papavassiliu T
    Int J Cardiol; 2014 Dec; 177(2):429-35. PubMed ID: 25304065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distribution of late gadolinium enhancement in end-stage hypertrophic cardiomyopathy and dilated cardiomyopathy: differential diagnosis and prediction of cardiac outcome.
    Machii M; Satoh H; Shiraki K; Saotome M; Urushida T; Katoh H; Takehara Y; Sakahara H; Ohtani H; Wakabayashi Y; Ukigai H; Tawarahara K; Hayashi H
    Magn Reson Imaging; 2014 Feb; 32(2):118-24. PubMed ID: 24315973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myocardial fibrosis and quality of life in patients with non-ischemic cardiomyopathy: a cardiovascular magnetic resonance imaging study.
    Khan R; Massel D; Stirrat J; Scholl D; Wisenberg G; Thompson T; Drangova M; White JA
    Int J Cardiovasc Imaging; 2013 Feb; 29(2):395-404. PubMed ID: 22875171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.